We are live on ! Find out more
XBIO icon

Xenetic Biosciences
XBIO

15 hedge funds and large institutions have $828K invested in Xenetic Biosciences in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

7% more funds holding

Funds holding: 14 → 15 (+1)

0.06% less ownership

Funds ownership: 0.78% → 0.72% (-0.06%)

22% less capital invested

Capital invested by funds: $1.07M → $828K (-$238K)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
2
Closed
3
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$60K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$30.3K
2
TRCT
Tower Research Capital (TRC)
New York
+$10.2K
3
GVAG
Great Valley Advisor Group
Delaware
+$8.57K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.33K
5
UBS Group
UBS Group
Switzerland
+$744

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$32.6K
2
JMPWA
JP Morgan Private Wealth Advisors
California
-$20K
3
Simplex Trading
Simplex Trading
Illinois
-$11.6K
4
Osaic Holdings
Osaic Holdings
Arizona
-$1K
5
Morgan Stanley
Morgan Stanley
New York
-$16
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$494K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$121K -$32.6K -4,035 -21%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$74K +$1.33K +165 +2%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$30K +$30.3K +3,752 New
State Street
5
State Street
Massachusetts
$28K – – –
JEST
6
JTC Employer Solutions Trustee
Jersey
$21K – – –
SPIA
7
Steward Partners Investment Advisory
New York
$15K – – –
Northern Trust
8
Northern Trust
Illinois
$14K – – –
TRCT
9
Tower Research Capital (TRC)
New York
$12K +$10.2K +1,258 +699%
Morgan Stanley
10
Morgan Stanley
New York
$10K -$16 -2 -0.2%
GVAG
11
Great Valley Advisor Group
Delaware
$8K +$8.57K +1,060 New
UBS Group
12
UBS Group
Switzerland
$1K +$744 +92 New
JMPWA
13
JP Morgan Private Wealth Advisors
California
– -$20K -2,000 Closed
Simplex Trading
14
Simplex Trading
Illinois
– -$11.6K -1,429 Closed
Osaic Holdings
15
Osaic Holdings
Arizona
– -$1K -60 Closed
Wells Fargo
16
Wells Fargo
California
– +$8 +1 +13%
Fidelity Investments
17
Fidelity Investments
Massachusetts
– +$24 +3 New

XBIO Hedge Fund Activity: Q2 2022 in Review

15 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q2 2022, worth a combined $828K — down 22% from $1.07M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new XBIO positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $30.3K. The largest seller was Renaissance Technologies, cutting an estimated $32.6K.

  • 15 institutional investors held Xenetic Biosciences (XBIO) as of Q2 2022, up from 14 in Q1 2022.
  • Funds reported $828K of Xenetic Biosciences stock for Q2 2022, down 22% quarter-over-quarter.
  • 4 funds opened new Xenetic Biosciences positions in Q2 2022 and 3 closed out, a net change of +1 holder.
  • The largest Xenetic Biosciences buyer in Q2 2022 was Susquehanna International Group, an estimated $30.3K added.
  • The largest Xenetic Biosciences seller in Q2 2022 was Renaissance Technologies, an estimated $32.6K sold.

Based on aggregated 13F filings for Q2 2022.